Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients

Completed

Conditions studied: Celiac Disease

In brief

This is an evaluation of celiac-specific patient reported outcome instruments in celiac disease patients.

Key facts

Study ID

NCT01560169

Run by

Alvine Pharmaceuticals Inc.

People needed

110

Starts

2012-03-01

Expected to finish

2013-09-01

Last updated by the study team

2013-10-10

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• History of biopsy proven celiac disease
• Adherence to a gluten-free diet (established patients only)
• TG2 negative (established patients only)
• TG2 positive (newly diagnosed patients only)
• Signed informed consent

You may not qualify if…

• History of IgE-mediated reactions to gluten
• Significant laboratory abnormalities
• History of untreated or GI disease
• Positive pregnancy test
• Any medical condition which could adversely affect study participation

Where it is running

• University of California, San Diego — La Jolla, California, United States
• Kaiser Permanente Southern California, Allergy Department — San Diego, California, United States
• University of Colorado, Denver — Aurora, Colorado, United States
• University of Chicago Celiac Disease Center — Chicago, Illinois, United States
• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
• Mayo Clinic — Rochester, Minnesota, United States
• Columbia University — New York, New York, United States
• Cleveland Clinic — Cleveland, Ohio, United States
• Thomas Jefferson University — Philadelphia, Pennsylvania, United States
• University of Alberta — Edmonton, Alberta, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.